Journal of Vascular Surgery
Volume 50, Issue 6 , Pages 1369-1376 , December 2009

Prediction rule for cardiovascular events and mortality in peripheral arterial disease patients: Data from the prospective Second Manifestations of ARTerial disease (SMART) cohort study

  • Ralf W. Sprengers, MD

      Affiliations

    • Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands
    • Department of Nephrology & Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands
    • Corresponding Author InformationReprint requests: Ralf W. Sprengers, MD, University Medical Center Utrecht HP G.04.130, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
    • ,
  • Kristel J.M. Janssen, PhD

      Affiliations

    • Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Frans L. Moll, MD, PhD

      Affiliations

    • Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Marianne C. Verhaar, MD, PhD

      Affiliations

    • Department of Nephrology & Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Yolanda van der Graaf, MD, PhD

      Affiliations

    • Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • SMART Study Group

      Affiliations

    • Please see the Appendix for a list of the SMART Study Group participants.

Received 21 April 2009 ,Accepted 3 July 2009.

References 

  1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33(suppl 1):S1–S75
  2. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317–1324
  3. Hankey GJ. Vascular disease of the heart, brain and limbs: new insights into a looming epidemic. Lancet. 2005;366:1753–1754
  4. Hirsch AT, Halverson SL, Treat-Jacobson D, Hotvedt PS, Lunzer MM, Krook S, et al. The Minnesota regional peripheral arterial disease screening program: toward a definition of community standards of care. Vasc Med. 2001;6:87–96
  5. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295:180–189
  6. Steg PG, Bhatt DL, Wilson PW, D'Agostino R, Ohman EM, Rother J, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007;297:1197–1206
  7. Cacoub PP, Abola MT, Baumgartner I, Bhatt DL, Creager MA, Liau CS, et al. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis. 2009;204:e86–e92
  8. Haugen S, Casserly IP, Regensteiner JG, Hiatt WR. Risk Assessment in the patient with established peripheral arterial disease. Vasc Med. 2007;12:343–350
  9. Simons PC, Algra A, van de Laak MF, Grobbee DE, van der GY. Second Manifestations of ARTerial Disease (SMART) study: rationale and design. Eur J Epidemiol. 1999;15:773–781
  10. McHugh GS, Butcher I, Steyerberg EW, Lu J, Mushkudiani N, Marmarou A, et al. Statistical approaches to the univariate prognostic analysis of the IMPACT database on traumatic brain injury. J Neurotrauma. 2007;24:251–258
  11. Akaike H. A new look at the statistical model identification. IEEE Transactions on Automatic Control. 1974;19:716–723
  12. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–387
  13. de Jong S. Hyperhomocysteinaemia in patients with peripheral arterial occlusive disease. Clin Chem Lab Med. 2001;39:714–716
  14. Schernthaner GH, Plank C, Minar E, Bieglmayer C, Koppensteiner R, Schernthaner G. No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease. Eur J Clin Invest. 2006;36:333–339
  15. Albert CM, Cook NR, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA. 2008;299:2027–2036
  16. Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, et al. Prognostic significance of the centers for disease control/american heart association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation. 2007;115:1528–1536
  17. Beckman JA, Preis O, Ridker PM, Gerhard-Herman M. Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death). Am J Cardiol. 2005;96:1374–1378
  18. Stuveling EM, Hillege HL, Bakker SJ, Gans RO, de Jong PE, de ZD. C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int. 2003;63:654–661
  19. Verhave JC, Hillege HL, Burgerhof JG, Gansevoort RT, de ZD, de Jong PE. The association between atherosclerotic risk factors and renal function in the general population. Kidney Int. 2005;67:1967–1973
  20. Greenland S, Finkle WD. A critical look at methods for handling missing covariates in epidemiologic regression analyses. Am J Epidemiol. 1995;142:1255–1264

 Competition of interest: none.

 The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.

PII: S0741-5214(09)01567-5

doi: 10.1016/j.jvs.2009.07.095

Journal of Vascular Surgery
Volume 50, Issue 6 , Pages 1369-1376 , December 2009

Article Tools

* Image Usage & Resolution